Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
71.34
Oct 20 • 3:59 PM ET Dollar change+1.19 Percentage change(1.70%)
Aftermarket Close
71.34
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
2.06B
Enterprise Value
1.77B
Income
135.04M
Sales
898.74M
Book/sh
28.56
Cash/sh
11.09
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
1333
IPO
May 03, 2018
P/E
15.49
Forward P/E
48.42
PEG
-
P/S
2.29
P/B
2.50
P/C
6.43
P/FCF
17.61
EV/EBITDA
24.83
EV/Sales
1.97
Quick Ratio
6.16
Current Ratio
8.55
Debt/Eq
0.04
LT Debt/Eq
0.04
Option/Short
Yes / Yes
EPS (ttm)
4.60
EPS next Y
1.47
EPS next Q
0.09
EPS this Y
-48.80%
EPS next Y
18.91%
EPS next 5Y
-7.61%
EPS past 3/5Y
- -
Sales past 3/5Y
30.77% 51.21%
EPS Y/Y TTM
161.83%
Sales Y/Y TTM
4.35%
EPS Q/Q
108.87%
Sales Q/Q
-7.60%
Insider Own
5.72%
Insider Trans
-0.30%
Inst Own
123.06%
Inst Trans
-4.58%
ROA
15.63%
ROE
17.96%
ROIC
15.80%
Gross Margin
86.13%
Oper. Margin
6.02%
Profit Margin
15.03%
SMA20
2.47%
SMA50
7.04%
SMA200
19.76%
Trades
Shs Outstand
28.91M
Shs Float
27.26M
52W High
147.03 -51.48%
52W Low
38.91 83.35%
Volatility
3.69% 4.45%
ATR (14)
2.96
RSI (14)
55.66
Beta
0.67
Rel Volume
0.92
Avg Volume
795.40K
Volume
733,286
Perf Week
3.60%
Perf Month
-5.78%
Perf Quarter
41.55%
Perf Half Y
37.11%
Perf YTD
-22.65%
Perf Year
-11.71%
Perf 3Y
-54.31%
Perf 5Y
-71.64%
Perf 10Y
-
Prev Close
70.15
Price
71.34
Change %
1.70%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHN RONDONIOfficerAug 24 '26Proposed Sale62.36643,991Aug 24 04:29 PM
Kelly Jason PSee RemarksAug 07 '26Sale59.5596357,34718,985Aug 11 07:13 PM
JASON P KELLYOfficerAug 07 '26Proposed Sale59.5596357,342Aug 07 04:08 PM
Rondoni JohnSee RemarksMay 15 '26Sale43.282,641114,30227,165May 19 04:05 PM
JOHN RONDONIOfficerMay 15 '26Proposed Sale43.282,641114,304May 15 04:17 PM
Rondoni JohnSee RemarksMay 14 '26Sale43.0170030,10729,806May 15 04:05 PM
JOHN RONDONIOfficerMay 14 '26Proposed Sale43.0170030,106May 14 04:34 PM
mcCormick ShawnDirectorMay 08 '26Sale45.3169631,53627,712May 11 04:05 PM
SHAWN T MCCORMICKDirectorMay 08 '26Proposed Sale45.5769631,717May 08 04:22 PM
Rondoni JohnSee RemarksJan 09 '26Sale100.0010910,90013,797Jan 12 04:05 PM
JOHN RONDONIOfficerJan 09 '26Proposed Sale95.0010910,355Jan 09 04:32 PM
mcCormick ShawnDirectorDec 02 '25Sale139.001,200166,80024,846Dec 04 04:05 PM
SHAWN T MCCORMICKDirectorDec 02 '25Proposed Sale126.341,200151,608Dec 02 04:27 PM
mcCormick ShawnDirectorNov 28 '25Sale127.482,000254,96026,046Dec 01 05:56 PM
SHAWN T MCCORMICKDirectorNov 28 '25Proposed Sale127.332,000254,660Nov 28 01:16 PM
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
FounderMr. Timothy P. Herbert
Senior VPMr. Bryan K. Phillips J.D.
Chief Strategy and Growth OfficerMr. Carlton W. Weatherby
Executive VP & CFOMr. Matthew J. Osberg
Chief Operations & Innovation OfficerMr. Jason P. Kelly